Skip to main content
51°
Rain
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bausch Health Companies Inc
(NY:
BHC
)
10.65
+0.16 (+1.53%)
Streaming Delayed Price
Updated: 12:07 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bausch Health Companies Inc
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma
March 06, 2024
Via
ACCESSWIRE
New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure
March 05, 2024
Via
ACCESSWIRE
Bausch Health Companies to Present at Cowen Annual Health Care Conference
March 01, 2024
Via
ACCESSWIRE
RBC Capital Maintains Sector Perform Rating for Bausch Health Companies: Here's What You Need To Know
February 23, 2024
Via
Benzinga
Bausch Health Announces Fourth-Quarter and Full-Year 2023 Results
February 22, 2024
Via
ACCESSWIRE
Preview: Bausch Health Companies's Earnings
February 21, 2024
Via
Benzinga
Salix Announces 2024 Gastrointestinal Health Scholars Program
February 12, 2024
Via
ACCESSWIRE
CORRECTION BY SOURCE: Solta Medical's Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China
January 18, 2024
Via
ACCESSWIRE
Solta Medical’s Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China
January 18, 2024
Via
ACCESSWIRE
A 'Toxic Byproduct of an Imperfect Higher Education System' — Famous Short Seller Known as 'The Assassin' Strikes Her Newest Target
February 08, 2024
Fahmi Quadir, featured in the Netflix series "Dirty Money" for her success in predicting and betting on the collapse of Valeant ...
Via
Benzinga
Bausch Health Announces Board Refreshment
February 01, 2024
Via
ACCESSWIRE
Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22
February 01, 2024
Via
ACCESSWIRE
CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S.
January 30, 2024
Via
ACCESSWIRE
Court of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute
January 07, 2024
Via
ACCESSWIRE
Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis
December 21, 2023
Via
ACCESSWIRE
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Bausch Health Unveils "Looking Forward" - A New DTC Television Campaign for Seasonal Affective Disorder (SAD)
October 26, 2023
Via
ACCESSWIRE
DUOBRII(TM) Lotion to Treat Moderate to Severe Plaque Psoriasis Now Available Through Quebec’s Public Drug Plan
December 18, 2023
Via
ACCESSWIRE
3 cheap 'stock'-ing stuffers Wall Street is bullish on
December 07, 2023
These three companies have Wall Street feeling bullish and are trading under $10, making them ideal ‘stock'-ing stuffers for hard to shop for traders.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
Salix in Collaboration with The U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders Establish the Inaugural Opioid-Induced Constipation (OIC) Awareness Day
December 05, 2023
Via
ACCESSWIRE
Bausch Health Companies Inc. (NYSE:BHC) Long Term Shareholder Notice: Investigation of Potential Wrongdoing
December 01, 2023
San Diego, CA -- (SBWIRE) -- 12/01/2023 -- An investigation on behalf of current long-term investors in shares of Bausch Health Companies Inc. (NYSE:BHC) concerning potential breaches of fiduciary...
Via
SBWire
The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis
November 10, 2023
Via
ACCESSWIRE
CORRECTION BY SOURCE: The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis
November 10, 2023
Via
ACCESSWIRE
As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD)
November 08, 2023
Via
ACCESSWIRE
US Stocks On Track For Solid Start Amid Lingering Fed Optimism: Traders Eye Earnings From Market Bellwether Apple
November 02, 2023
After the Federal Reserve‘s decision, the stock market rally is poised to gain momentum on Thursday, with stock futures indicating an uptick.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Bausch Health Announces Third-Quarter 2023 Results
November 02, 2023
Via
ACCESSWIRE
Wall Street On Track For Another Win Amid Interest Rate Buzz
November 01, 2023
Wall Street is looking to extend a winning streak, as investors prepare for the Federal Reserve's latest interest rate decision.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
U.S. District Court Dismisses Norwich's Lawsuit Against the FDA
November 01, 2023
Via
ACCESSWIRE
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
October 28, 2023
The U.S.
Via
Benzinga
Exposures
Product Safety
FDA Approves Cabtreo(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older
October 20, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.